These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 19343742

  • 1. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J, Khanwalkar H, Pereira R, Erb C, Voegel JJ, Collette P, Mauvais P, Bourguet W, Gronemeyer H, de Lera AR.
    Chembiochem; 2009 May 04; 10(7):1252-9. PubMed ID: 19343742
    [Abstract] [Full Text] [Related]

  • 2. C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
    Alvarez S, Khanwalkar H, Alvarez R, Erb C, Martínez C, Rodríguez-Barrios F, Germain P, Gronemeyer H, de Lera AR.
    ChemMedChem; 2009 Oct 04; 4(10):1630-40. PubMed ID: 19670208
    [Abstract] [Full Text] [Related]

  • 3. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC, Dawson MI, Reichert U.
    Drug Metab Rev; 1996 Oct 04; 28(1-2):105-19. PubMed ID: 8744592
    [Abstract] [Full Text] [Related]

  • 4. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
    Alvarez S, Alvarez R, Khanwalkar H, Germain P, Lemaire G, Rodríguez-Barrios F, Gronemeyer H, de Lera AR.
    Bioorg Med Chem; 2009 Jul 01; 17(13):4345-59. PubMed ID: 19482478
    [Abstract] [Full Text] [Related]

  • 5. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM, Standeven AM, Athanikar J, Kopper S, Castilleja O, Escobar M, Beard RL, Chandraratna RA.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):528-34. PubMed ID: 9262312
    [Abstract] [Full Text] [Related]

  • 6. Ligand recognition by RAR and RXR receptors: binding and selectivity.
    Sussman F, de Lera AR.
    J Med Chem; 2005 Oct 06; 48(20):6212-9. PubMed ID: 16190748
    [Abstract] [Full Text] [Related]

  • 7. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y, Dokmanovic M, Stein WD, Ardecky RJ, Roninson IB.
    Cancer Res; 2006 Sep 01; 66(17):8749-61. PubMed ID: 16951191
    [Abstract] [Full Text] [Related]

  • 8. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists.
    Germain P, Gaudon C, Pogenberg V, Sanglier S, Van Dorsselaer A, Royer CA, Lazar MA, Bourguet W, Gronemeyer H.
    Chem Biol; 2009 May 29; 16(5):479-89. PubMed ID: 19477412
    [Abstract] [Full Text] [Related]

  • 9. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR, Bourguet W, Altucci L, Gronemeyer H.
    Nat Rev Drug Discov; 2007 Oct 29; 6(10):811-20. PubMed ID: 17906643
    [Abstract] [Full Text] [Related]

  • 10. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M, Vivat V, Wurtz JM, Losson R, Chambon P, Moras D, Gronemeyer H.
    Chem Biol; 1999 Aug 29; 6(8):519-29. PubMed ID: 10421757
    [Abstract] [Full Text] [Related]

  • 11. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN, Liu G, James SY, Hobbs PD, Peterson VJ, Bhattacharya AA, Kolluri SK, Zhang XK, Leid M, Abagyan R, Liddington RC, Dawson MI.
    J Med Chem; 2004 Aug 26; 47(18):4360-72. PubMed ID: 15317450
    [Abstract] [Full Text] [Related]

  • 12. The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist).
    Takamatsu K, Takano A, Yakushiji N, Morohashi K, Morishita K, Matsuura N, Makishima M, Tai A, Sasaki K, Kakuta H.
    ChemMedChem; 2008 May 26; 3(5):780-7. PubMed ID: 18297677
    [Abstract] [Full Text] [Related]

  • 13. Expression of retinoid receptors in sebaceous cell carcinoma.
    Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B.
    J Cutan Pathol; 2006 Jan 26; 33(1):10-7. PubMed ID: 16441406
    [Abstract] [Full Text] [Related]

  • 14. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H.
    Nat Rev Drug Discov; 2007 Oct 26; 6(10):793-810. PubMed ID: 17906642
    [Abstract] [Full Text] [Related]

  • 15. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T, Kanayama T.
    Int J Dermatol; 2006 Nov 26; 45(11):1288-95. PubMed ID: 17076708
    [Abstract] [Full Text] [Related]

  • 16. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
    Klaholz BP, Mitschler A, Moras D.
    J Mol Biol; 2000 Sep 08; 302(1):155-70. PubMed ID: 10964567
    [Abstract] [Full Text] [Related]

  • 17. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
    Álvarez S, Lieb M, Martínez C, Khanwalkar H, Rodríguez-Barrios F, Álvarez R, Gronemeyer H, de Lera AR.
    ChemMedChem; 2015 Aug 08; 10(8):1378-91. PubMed ID: 26012882
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
    Yu KL, Spinazze P, Ostrowski J, Currier SJ, Pack EJ, Hammer L, Roalsvig T, Honeyman JA, Tortolani DR, Reczek PR, Mansuri MM, Starrett JE.
    J Med Chem; 1996 Jun 07; 39(12):2411-21. PubMed ID: 8691435
    [Abstract] [Full Text] [Related]

  • 19. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
    Kambayashi H, Odake Y, Takada K, Funasaka Y, Ichihashi M, Kato S.
    Br J Dermatol; 2005 Dec 07; 153 Suppl 2():30-6. PubMed ID: 16280019
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.